AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $20.15M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| DME | Ceasing to be a substantial holder - Precious Tori | 12/03/18 | ||
| DME | Half Year Accounts | 08/03/18 | ||
| DME | Results of Meeting | 08/03/18 | ||
| DME | Change of Director's Interest Notice TT | 08/03/18 | ||
| DME | Becoming a substantial holder Blue Ridge | 08/03/18 | ||
| DME | Change of Director's Interest Notice TT | 08/03/18 | ||
| DME | Commencement of Ono drill program | PRICE SENSITIVE | 06/03/18 | |
| DME | Ceasing to be a substantial holder Summerfell | 27/02/18 | ||
| DME Ceasing to be a substantial holder - Precious Tori | |||
| 12/03/18 | |||
| DME Half Year Accounts | |||
| 08/03/18 | |||
| DME Results of Meeting | |||
| 08/03/18 | |||
| DME Change of Director's Interest Notice TT | |||
| 08/03/18 | |||
| DME Becoming a substantial holder Blue Ridge | |||
| 08/03/18 | |||
| DME Change of Director's Interest Notice TT | |||
| 08/03/18 | |||
| DME Commencement of Ono drill program | |||
| 06/03/18 | PRICE SENSITIVE | ||
| DME Ceasing to be a substantial holder Summerfell | |||
| 27/02/18 | |||
